Violation Tracker Parent Company Summary
|Top 10 Primary Offense Types||Penalty Total||Number of Records|
|off-label or unapproved promotion of medical products||$495,000,000||2|
|kickbacks and bribery||$390,000,000||1|
|wage and hour violation||$99,199,443||2|
|Foreign Corrupt Practices Act||$25,000,000||1|
|HHS civil monetary penalties||$12,870,000||2|
|export control violation||$8,100,000||1|
|economic sanction violation||$7,785,650||2|
|workplace safety or health violation||$142,998||4|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.
ALCON; ALCON PHARMACEUTICALS AND ALCON LABS; CHIRON; NOVARTIS; Novartis Corporation; Novartis Corporation and Alcon Laboratories; NOVARTIS VACCINES AND DIAGNOSTICS AND NOVARTIS PHARMACEUTICALS; SANDOZ
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
Individual Penalty Records:Click on the company or penalty amount for more information on each case.
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|Novartis Pharmaceuticals Corporation||off-label or unapproved promotion of medical products||2010||FDA||$422,500,000|
|Novartis Pharmaceuticals||kickbacks and bribery||2015||USAO||$390,000,000|
|Novartis Corporation||employment discrimination||2010||private lawsuit-federal||$175,000,000|
|Novartis||wage and hour violation||2012||private lawsuit-federal||$99,000,000|
|Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation||off-label or unapproved promotion of medical products||2010||FDA||$72,500,000|
|Novartis AG||Foreign Corrupt Practices Act||2016||SEC||$25,000,000|
|Sandoz, Inc.||HHS civil monetary penalties||2015||HHSOIG||$12,640,000|
|Alcon Pharmaceuticals Ltd. and Alcon Laboratories, Inc.||export control violation||2016||BIS||$8,100,000|
|Novartis Corporation and Alcon Laboratories||employment discrimination||2016||private lawsuit-federal||$8,000,000|
|Alcon Laboratories, Inc||economic sanction violation||2016||OFAC||$7,617,150|
|Sandoz, Inc.||HHS civil monetary penalties||2011||HHSOIG||$230,000|
|Alcon Research, Ltd.||wage and hour violation||2011||WHD||$199,443|
|Chiron Corporation Ltd||economic sanction violation||2004||OFAC||$168,500|
|CHIRON CORPORATION||workplace safety or health violation||2000||OSHA||$90,140|
|Novartis Pharmaceuticals||employment discrimination||2013||OFCCP||$51,594|
|ALCON RESEARCH, LTD||workplace safety or health violation||2010||OSHA||$30,300|
|ALCON LABORATORIES, INC.||workplace safety or health violation||2016||OSHA||$16,480|
|NOVARTIS PRODUCTS||environmental violation||2000||EPA||$13,200|
|NOVARTIS PHARMACEUTICALS CORPORATION||benefit plan administrator violation||2006||EBSA||$10,001|
|Novartis Animal Health US, Inc.||environmental violation||2006||EPA||$6,500|
|NOVARTIS CONSUMER HEALTH INC.||workplace safety or health violation||2013||OSHA||$6,078|
|NOVARTIS CONSUMER HEALTH, INC.||environmental violation||2000||EPA||$5,000|